RZSMF yields 7.80% · MRK yields 2.76%● Live data
📍 RZSMF pulled ahead of the other in Year 1
Combined, RZSMF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RZSMF + MRK for your $10,000?
RCS MediaGroup S.p.A. operates as a multimedia publishing company in Italy, Spain, and internationally. The company publishes newspapers under the Corriere della Sera, Corriere Salute, SOLFERINO, Buone Notizie, Dataroom, La Gazzetta dello Sport, El Mundo, Marca, Expansión, L'Economia, La Lettura, ViviMilano, CI-Corriere Innovazione, and Gazzetta Selection names; and magazines in the women, oggi, interior design, men and lifestyle, travel, and other areas under the MARCA MOTOR, Oggi, AMICA, 7, Abitare, Living, Style, TELVA, Io Donna, DOVE, Sportweek, Insieme, Metrópoli, ACTUALIDAD ECONÓMICA, Fuera de Serie, Italian Style, Io e il mio Bambino, SFERA editore, Oggi Cucino, Style Piccoli, Quimamme, Yo Dona, Sano & Leggero, Bimbinfiera, and Oggi Enigmistica names. It also operates MYBEAUTYBOX, corrierstore.it, doveclub.it, quimammeshop.it, gazzettastore.it, dirittierisposte.it, buonpertutti.corriere.it, and magic.gazzetta.it websites; and TV and radio channels under the Dove Lifestyle, Lei, Radio Marca, Caccia e Pesca, and Corriere TV names. In addition, the company offers print and digital advertising solutions under the RCS PUBBLICITA, m-dis, Imagine, CORREO FARMACÉUTICO, DIARIO MÉDICO, and Infanzia names, as well as sells mobile phone top-up services; and organizes sports and other events, such as roadshows, guerrilla events, sampling, trade marketing, and press conferences under the RCS Sport, SALA BUZZATI, and Last Lap names. The company was formerly known as Holding di Partecipazioni Industriali S.p.A. and changed its name to RCS MediaGroup S.p.A. in 2003. RCS MediaGroup S.p.A. is based in Milan, Italy.
Full RZSMF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.